Clinical Research Directory
Browse clinical research sites, groups, and studies.
Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)
Sponsor: 424 General Military Hospital
Summary
A 24-month prospective, open-label, randomized, multicenter, multinational, non-inferiority pragmatic clinical trial evaluating zoledronate single or double infusion versus oral alendronate following denosumab
Official title: The Effectiveness of Single or Repeat Zoledronate Infusion Versus Oral Alendronate in Consolidating the Bone Accrual Achieved With Denosumab: a Study Organised by the European Calcified Tissue Society
Key Details
Gender
FEMALE
Age Range
50 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
125
Start Date
2023-11-28
Completion Date
2027-11
Last Updated
2025-04-27
Healthy Volunteers
No
Conditions
Interventions
Zoledronate or Alendronate
infusion (for zoledronate) or oral digestion (for alendronate)
Locations (9)
Univ. Lille, CHU Lille
Lille, France
251 Hellenic Airforce and VA General Hospital
Athens, Greece
First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens
Athens, Greece
, KAT General Hospital
Athens, Greece
424 General Military Hospital
Thessaloniki, Greece
Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico
Milan, Italy
Campus Bio-Medico University
Roma, Italy
Department of Medicine, Surgery and Neurosciences, University of Siena
Siena, Italy
University-Hospital S. Maria della Misericordia
Udine, Italy